Stephan D. Voss

9.8k total citations · 2 hit papers
173 papers, 6.8k citations indexed

About

Stephan D. Voss is a scholar working on Neurology, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Stephan D. Voss has authored 173 papers receiving a total of 6.8k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Neurology, 42 papers in Radiology, Nuclear Medicine and Imaging and 38 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Stephan D. Voss's work include Neuroblastoma Research and Treatments (48 papers), Lymphoma Diagnosis and Treatment (25 papers) and Medical Imaging Techniques and Applications (21 papers). Stephan D. Voss is often cited by papers focused on Neuroblastoma Research and Treatments (48 papers), Lymphoma Diagnosis and Treatment (25 papers) and Medical Imaging Techniques and Applications (21 papers). Stephan D. Voss collaborates with scholars based in United States, Germany and Canada. Stephan D. Voss's co-authors include Brenda J. Weigel, Susan M. Blaney, Paul M. Sondel, Arne Skerra, Peter C. Adamson, Peter Gruß, Elizabeth Fox, Anamaris M. Colberg‐Poley, John M. Maris and Joel M. Reid and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Stephan D. Voss

166 papers receiving 6.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study

2013 477 citations Yaël P. Mossé, Stephan D. Voss et al. profile →
Effect of Tandem Autologous Stem Cell Transplant vs Single Transplant on Event-Free Survival in Patients With High-Risk Neuroblastoma

2019 214 citations Daphne A. Haas‐Kogan, Stephan D. Voss et al. profile →

Peers

Countries citing papers authored by Stephan D. Voss

Since Specialization

Citations

This map shows the geographic impact of Stephan D. Voss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephan D. Voss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephan D. Voss more than expected).

Fields of papers citing papers by Stephan D. Voss

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephan D. Voss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephan D. Voss. The network helps show where Stephan D. Voss may publish in the future.

Co-authorship network of co-authors of Stephan D. Voss

This figure shows the co-authorship network connecting the top 25 collaborators of Stephan D. Voss. A scholar is included among the top collaborators of Stephan D. Voss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephan D. Voss. Stephan D. Voss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Radiation Concepts and Considerations for Pediatric Cancer Predisposition Syndrome Surveillance: A Report from the 2023 AACR Childhood Cancer Predisposition Workshop 2025 ·Clinical Cancer Research ·Stephan D. Voss, Mary‐Louise C. Greer, Andréa S. Doria, (unknown), (unknown), Garrett M. Brodeur, Lisa J. States	1
2	Update on Surveillance in Von Hippel–Lindau Disease 2025 ·Clinical Cancer Research ·Surya P. Rednam, (unknown), Anita Villani, Garrett M. Brodeur, Lisa J. States, Andréa S. Doria, Junne Kamihara, Kami Wolfe Schneider, Stephan D. Voss, Elysa Widjaja, Kristin Zelley, Yoshiko Nakano, Kristian W. Pajtler, Maria Isabel Achatz, David Malkin, Lisa Diller, Bailey Gallinger, Chieko Tamura, Jonathan D. Wasserman	1
3	Update on Tumor Surveillance for Children with Hereditary Pheochromocytoma/Paraganglioma Syndromes 2025 ·Clinical Cancer Research ·Surya P. Rednam, Junne Kamihara, (unknown), Garrett M. Brodeur, Lisa J. States, Stephan D. Voss, Anita Villani, Kristin Zelley, David Malkin, Yoshiko Nakano, Andréa S. Doria, Elysa Widjaja, Kristian W. Pajtler, Kami Wolfe Schneider, Maria Isabel Achatz, Lisa Diller, Bailey Gallinger, Chieko Tamura, Jonathan D. Wasserman	1
4	Neuroblastoma Predisposition and Surveillance—An Update from the 2023 AACR Childhood Cancer Predisposition Workshop 2024 ·Clinical Cancer Research ·Junne Kamihara, Lisa Diller, William D. Foulkes, Orli Michaeli, Yoshiko Nakano, Kristian W. Pajtler, (unknown), Sarah Scollon, Douglas R. Stewart, Stephan D. Voss, Rosanna Weksberg, Jordan R. Hansford, Garrett M. Brodeur	6
5	A Phase I/II Trial of Nivolumab plus Ipilimumab in Children and Young Adults with Relapsed/Refractory Solid Tumors: A Children's Oncology Group Study ADVL1412 2022 ·Clinical Cancer Research ·Kara L. Davis, Elizabeth Fox, (unknown), Joel M. Reid, (unknown), Charles G. Minard, Stephan D. Voss, Stacey L. Berg, Brenda J. Weigel, Crystal L. Mackall	43
6	Gamma Secretase Inhibition for a Child With Metastatic Glomus Tumor and Activated NOTCH1 2022 ·JCO Precision Oncology ·Ellen Zhang, Amber Miller, Catherine Clinton, (unknown), Stephan D. Voss, Jon C. Aster, Alanna J. Church, Reza Rahbar, (unknown), Katherine A. Janeway, Steven G. DuBois	3
7	Imaging of pediatric hematopoietic stem cell transplant recipients: A COG Diagnostic Imaging Committee/SPR Oncology Committee White Paper 2022 ·Pediatric Blood & Cancer ·Sherwin S. Chan, Ailish Coblentz, Aashim Bhatia, Sue C. Kaste, Joyce Mhlanga, Marguerite T. Parisi, Paul G. Thacker, Stephan D. Voss, Elizabeth K. Weidman, Marilyn J. Siegel	2
8	Imaging recommendations in pediatric lymphoma: A COG Diagnostic Imaging Committee/SPR Oncology Committee White Paper 2022 ·Pediatric Blood & Cancer ·Joyce Mhlanga, Hollie Lai, Adina Alazraki, (unknown), Helen Nadel, Neeta Pandit‐Taskar, Jing Qi, Dhanashree Rajderkar, Stephan D. Voss, (unknown), Kathleen M. McCarten	11
9	⁶⁸Ga‐DOTATATE PET and functional imaging in pediatric pheochromocytoma and paraganglioma 2022 ·Pediatric Blood & Cancer ·(unknown), Neha Kwatra, Laura A. Drubach, Christopher B. Weldon, Katherine A. Janeway, Steven G. DuBois, Junne Kamihara, Stephan D. Voss	4
10	Activity of Crizotinib in Patients with ALK-Aberrant Relapsed/Refractory Neuroblastoma: A Children's Oncology Group Study (ADVL0912) 2021 ·Clinical Cancer Research ·Jennifer H. Foster, Stephan D. Voss, David Hall, Charles G. Minard, Frank M. Balis, Keith D. Wilner, Stacey L. Berg, Elizabeth Fox, Peter C. Adamson, Susan M. Blaney, Brenda J. Weigel, Yaël P. Mossé	61
11	Juvenile Granulosa Cell Tumor as the Presenting Feature of McCune-Albright Syndrome 2021 ·Journal of the Endocrine Society ·Brynn E. Marks, (unknown), Wallace Bourgeois, A. Lindsay Frazier, Stephan D. Voss, Marc R. Laufer, Catherine M. Gordon, Laurie E. Cohen	1
12	Phase I Clinical Trial of the Wee1 Inhibitor Adavosertib (AZD1775) with Irinotecan in Children with Relapsed Solid Tumors: A COG Phase I Consortium Report (ADVL1312) 2019 ·Clinical Cancer Research ·Kristina A. Cole, Sharmistha Pal, Rachel A. Kudgus, Heba Ijaz, Xiaowei Liu, Charles G. Minard, Bruce Pawel, John M. Maris, Daphne A. Haas‐Kogan, Stephan D. Voss, Stacey L. Berg, Joel M. Reid, Elizabeth Fox, Brenda J. Weigel	48
13	A Phase II Study of Alisertib in Children with Recurrent/Refractory Solid Tumors or Leukemia: Children's Oncology Group Phase I and Pilot Consortium (ADVL0921) 2019 ·Clinical Cancer Research ·Yaël P. Mossé, Elizabeth Fox, David T. Teachey, Joel M. Reid, Stephanie L. Safgren, Hernán Carol, Richard B. Lock, Peter J. Houghton, Malcolm A. Smith, David Hall, Donald A. Barkauskas, Mark Krailo, Stephan D. Voss, Stacey L. Berg, Susan M. Blaney, Brenda J. Weigel	79
14	Phase 1/2 trial of talazoparib in combination with temozolomide in children and adolescents with refractory/recurrent solid tumors including Ewing sarcoma: A Children's Oncology Group Phase 1 Consortium study (ADVL1411) 2019 ·Pediatric Blood & Cancer ·Eric S. Schafer, Rachel E. Rau, Stacey L. Berg, Xiaowei Liu, Charles G. Minard, Alexander J.R. Bishop, July Carolina Romero, John Hicks, Marvin D. Nelson, Stephan D. Voss, Joel M. Reid, Elizabeth Fox, Brenda J. Weigel, Susan M. Blaney	52
15	Von Hippel–Lindau and Hereditary Pheochromocytoma/Paraganglioma Syndromes: Clinical Features, Genetics, and Surveillance Recommendations in Childhood 2017 ·Clinical Cancer Research ·Surya P. Rednam, Ayelet Erez, Harriet Druker, Katherine A. Janeway, Junne Kamihara, Wendy Kohlmann, Katherine L. Nathanson, Lisa J. States, Gail E. Tomlinson, Anita Villani, Stephan D. Voss, Joshua D. Schiffman, Jonathan D. Wasserman	174
16	How we read pediatric PET/CT: indications and strategies for image acquisition, interpretation and reporting 2017 ·Cancer Imaging ·Gabrielle Colleran, Neha Kwatra, (unknown), Frederick D. Grant, Laura A. Drubach, Michael J. Callahan, Robert MacDougall, Frederic H. Fahey, Stephan D. Voss	14
17	Evaluation of the utility of ^99mTc‐MDP bone scintigraphy versus MIBG scintigraphy and cross‐sectional imaging for staging patients with neuroblastoma 2017 ·Pediatric Blood & Cancer ·(unknown), (unknown), Frederick D. Grant, Suzanne Shusterman, Steven G. DuBois, A. Lindsay Frazier, Stephan D. Voss	9
18	Phase I Pharmacokinetic and Pharmacodynamic Study of Pazopanib in Children With Soft Tissue Sarcoma and Other Refractory Solid Tumors: A Children's Oncology Group Phase I Consortium Report 2013 ·Journal of Clinical Oncology ·Julia Glade Bender, Alice Lee, Joel M. Reid, Sylvain Baruchel, Timothy P. L. Roberts, Stephan D. Voss, Bing Wu, Charlotte H. Ahern, Ashish M. Ingle, Pamela Jo Harris, Brenda J. Weigel, Susan M. Blaney	125
19	Surveillance Computed Tomography Imaging and Detection of Relapse in Intermediate- and Advanced-Stage Pediatric Hodgkin's Lymphoma: A Report From the Children's Oncology Group 2012 ·Journal of Clinical Oncology ·Stephan D. Voss, Lu Chen, Louis S. Constine, Allen R. Chauvenet, Thomas J. FitzGerald, Sue C. Kaste, Thomas L. Slovis, Cindy L. Schwartz	44
20	Phase I/II Trial and Pharmacokinetic Study of Cixutumumab in Pediatric Patients With Refractory Solid Tumors and Ewing Sarcoma: A Report From the Children's Oncology Group 2011 ·Journal of Clinical Oncology ·Suman Malempati, Brenda J. Weigel, Ashish M. Ingle, Charlotte H. Ahern, Julie M. Carroll, Charles T. Roberts, Joel M. Reid, Stephen C. Schmechel, Stephan D. Voss, (unknown), Helen X. Chen, Mark Krailo, Peter C. Adamson, Susan M. Blaney	147

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact